News for LICT Corporation (LICT)

TRAVERSE CITY, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- MachTen, Inc. (”œMACT”) ( MACT) today reported financial results for the quarter ended September 30

**media[482606]**

LICT Corporation Closes on $100 Million Financing

TRAVERSE CITY, Mich., July 31, 2024 (GLOBE NEWSWIRE) -- MachTen, Inc. (“MACT”) (OTC: MACT) today reported audited financial results for the year ended...

Alluvial Fund returned 3.2% in the fourth quarter, bringing our return to 15.1% for the full year. Click here to read the full fund letter.

ACAM extended and increased through 2038 with Extended A-CAM Program Spinoff of MachTen complete-LICT holders receive 150 shares of MachTen per LICT share …

MachTen, Inc. Reports Results for the Third Quarter 2023...

TRAVERSE CITY, Mich., Aug. 29, 2023 (GLOBE NEWSWIRE) -- MachTen, Inc. (“MACT”) (OTC: MACT) today reported its operating results for the quarter ended...

Weitz Partners Value Fund Institutional Class returned +2.03% for Q1 2023 compared to +7.18% for the Russell 3000. Click here to read the full fund letter.

GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Discussion of markets and holdings

Alluvial Fund returned 4.2% in the fourth quarter, slightly behind benchmarks. Click here to read the full fund letter.

Alluvial Fund declined 2.2% in the third quarter of 2022, in line with comparable indexes. Click here to read the full fund letter.

Alluvial Fund declined 9.9% in the second quarter and is down 16.5% year-to-date. Click here to read the full fund letter.

Alluvial Fund commentary for the fourth quarter ended December 31, 2021.

Alluvial Fund commentary for the third quarter ended September 2021, discussing the IPO of P10 Holdings Inc (NYSE:PX).

Alluvial Fund, LP continues to enjoy a good year, returning 7.0% in the second quarter. Returns for the quarter, year-to-date

LICT Corporation (the "Corporation"; OTC Pink®: LICT) is announcing that its Board of Directors (the "Board") has initiated a strategic review to accelerate and